We’re proud to announce that AtriCure has been Great Place To Work® Certified™ for 2025 in the Netherlands, United Kingdom, and Australia! This prestigious recognition is a direct reflection of the positive experiences shared by our employees.​

Discover what sets AtriCure apart by hearing from our talented team, and explore exciting career opportunities on our website at: <a href="https://bit.ly/3w92MrJ&quot; target="_blank">https://bit.ly/3w92MrJ</a&gt;​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=GreatPlacetoWork&highli…; target='_blank'>#GreatPlacetoWork</a>

Post-amputation patients often suffer from post-surgical pain. With the new cryoXT™ probe, surgeons can now provide their patients with a non-opioid option to provide a more comfortable recovery experience.​

Find all the details here: <a href="https://t.co/T5yRbifPNE&quot; target="_blank">https://t.co/T5yRbifPNE</a&gt;

The BoxX-NoAF clinical trial will set out to evaluate the safety and effectiveness of cardiac ablation and LAAE during cardiac surgery for the prevention of new-onset Afib in cardiac surgery patients with risk factors, but no history of Afib.

For more trial details, visit:

Patrick Myers, Secretary General of EACTS - European Association for Cardio-Thoracic Surgery, invites you to join the 20th edition of Navigating the Maze in Barcelona, held in collaboration with AtriCure. This landmark course will deliver insights into state-of-the-art treatments, featuring the latest clinical evidence, interactive case-based discussions, and practical guidance on implementing AF and hybrid treatment strategies in daily practice.​
​
Last chance to register at navigatingthemaze.eu
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=NavigatingTheMaze&highl…; target='_blank'>#NavigatingTheMaze</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a>​

Rhythm control through surgical ablation isn’t just about rhythm — it’s about preventing heart failure and improving long-term outcomes. ​​

Survivability increases when rhythm is restored.

The material and design of AtriCure’s CryoICE® cryoablation probes deliver robust, continuous lesions — the foundation for effective and durable ablations.​​

Reliability matters. Outcomes matter.​​

Learn more about what sets AtriCure’s CryoICE probes apart:

The cryoSPHERE® MAX™ Probe has 60% more tissue contact*, optimizing the freeze cycle with a recommended freeze time of 60 seconds. It is faster to reach optimal temperature, offering surgeons significant improvement when using the device for post-operative pain management. ​​

Learn more: <a href="https://lnkd.in/ePfhUs4g&quot; target="_blank">https://lnkd.in/ePfhUs4g</a&gt;​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ThoracicSurgery&highlig…; target='_blank'>#ThoracicSurgery</a>​​
​
*compared to the cryoSPHERE probe's 8mm ball

Empowering Allied Healthcare Professionals through collaboration and education.

Today in Amsterdam, we were proud to host the Allied Healthcare Professionals Course in collaboration with EACTS - European Association for Cardio-Thoracic Surgery. Uniting surgical care practitioners, advanced nurse practitioners, and cardiac nurses from across Europe for a hands-on day of learning, collaboration and shared experience.
 
This initiative strengthens our shared mission to raise awareness of AF detection and treatment, while advancing clinical skills and improving patient outcomes in AF care within cardiac surgery.
 
The next AHP Course will take place on 12 May 2026.

Find out more: <a href="https://afconnect.eu/&quot; target="_blank">https://afconnect.eu/</a&gt;

EP Dr. David DeLurgio shares warning signs of Afib &amp; markers like left atrial enlargement. Left untreated, Afib can progress to long-standing persistent Afib.​

Discover the therapy providing Advanced Afib patients durable relief at: <a href="https://t.co/DuJ3o5OyQY&quot; target="_blank">https://t.co/DuJ3o5OyQY</a&gt; ​

<a href="https://twitter.com/hashtag/HybridAFTherapy?src=hashtag_click&quot; target="_blank">#HybridAFTherapy</a>

The cryoXT™ probe offers a breakthrough non-opioid therapy designed to help reduce residual and phantom limb pain—bringing comfort and confidence to recovery.

Learn more about how cryoXT is changing the standard of care: <a href="https://t.co/MaJxOHM6W8&quot; target="_blank">https://t.co/MaJxOHM6W8</a&gt;